U.S., EU Move To Harmonize Drug Approval Scheme

Law360, New York (November 28, 2007, 12:00 AM EST) -- Pharmaceutical industry representatives have urged regulators from the United States and the European Union to better harmonize their drug approval and marketing authorization requirements in order to ease the burden on multinational businesses.

The EC hosted the Transatlantic Administrative Simplification Workshop in Brussels on Wednesday. The U.S. Food and Drug Administration, the European Commission, the European Medicines Agency, advocacy groups and companies attended.

The workshop aimed to set a road map on how best to streamline the way U.S. and European regulators approve medications and marketing...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.